JWA
ALNY icon

JFS Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

JFS Wealth Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Hold
40
– – ﹤0.01% 934
2026
Q1 		$13.2K Sell
40
-5
-11% -$1.7K ﹤0.01% 850
2025
Q4 		$17.9K Buy
45
+10
+29% +$4.43K ﹤0.01% 781
2025
Q3 		$16K Hold
35
– – ﹤0.01% 743
2025
Q2 		$11.4K Hold
35
– – ﹤0.01% 825
2025
Q1 		$9.45K Buy
35
+9
+35% +$2.31K ﹤0.01% 896
2024
Q4 		$6.12K Buy
26
+2
+8% +$526 ﹤0.01% 1050
2024
Q3 		$6.6K Buy
24
+3
+14% +$781 ﹤0.01% 1015
2024
Q2 		$5.1K Hold
21
– – ﹤0.01% 1063
2024
Q1 		$3.14K Buy
21
+6
+40% +$1K ﹤0.01% 1280
2023
Q4 		$2.87K Sell
15
-11
-42% -$1.87K ﹤0.01% 1274
2023
Q3 		$4.61K Buy
26
+5
+24% +$954 ﹤0.01% 1020
2023
Q2 		$3.99K Buy
21
+8
+62% +$1.59K ﹤0.01% 1100
2023
Q1 		$2.6K Sell
13
-11
-46% -$2.31K ﹤0.01% 1268
2022
Q4 		$5.7K Hold
24
– – ﹤0.01% 940
2022
Q3 		$5K Buy
24
+14
+140% +$2.67K ﹤0.01% 959
2022
Q2 		$1K Sell
10
-5
-33% -$709 ﹤0.01% 1452
2022
Q1 		$2K Buy
15
+5
+50% +$762 ﹤0.01% 1363
2021
Q4 		$2K Buy
+10
New +$1.86K ﹤0.01% 1018

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JFS Wealth Advisors's ALNY Position: Q2 2026 in Review

JFS Wealth Advisors held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 40 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #934.

JFS Wealth Advisors first reported a position in ALNY in Q4 2021 and has held it in 19 quarters since. The position peaked at $17.9K in Q4 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • JFS Wealth Advisors held 40 shares of Alnylam Pharmaceuticals worth $12K as of Q2 2026.
  • JFS Wealth Advisors left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #934 holding.
  • JFS Wealth Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • JFS Wealth Advisors's Alnylam Pharmaceuticals position peaked at $17.9K in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.